Preoperative biopsy underestimates tumour budding but retains prognostic value in oral squamous cell carcinoma
- 1Institute of Pathology, University Hospital, Rheinisch Westfälische Technische Hochschule (RWTH) Aachen University , ,
- 2Center for Integrated Oncology (CIO), CIO Aachen Bonn Cologne Duesseldorf (ABCD) , ,
Abstract
Introduction: Tumour budding is an established prognostic marker in oral squamous cell carcinoma (OSCC), but its reliability and prognostic performance in preoperative biopsy specimens remain uncertain. This study compared tumour budding assessment in matched biopsy and resection specimens and evaluated their respective prognostic value.
Methods: We retrospectively analysed 256 patients with OSCC and matched preoperative biopsy and resection specimens. Tumour budding at the invasive front was assessed on hematoxylin and eosin-stained sections according to the International Tumour Budding Consensus Conference criteria and agreement between biopsy- and resection-based assessment was evaluated alongside associations with clinicopathological characteristics, disease-specific survival and occult nodal metastasis using logistic regression and Cox proportional hazards models.
Results: Biopsy-derived tumour budding showed only weak correlation with resection findings and systematically underestimated high tumour budding, resulting in poor categorical agreement (κ = 0.11) and low sensitivity (9.8%) despite high specificity (98.9%). Nevertheless, both biopsy- and resection-based tumour budding were associated with disease-specific survival when mutually adjusted for each other. The C-index was numerically higher for resection-based than biopsy-based assessment (0.72 vs. 0.60), with only a modest increase when both measures were combined (C-index 0.74). Both biopsy- and resection-derived tumour budding were also associated with local recurrence and distant metastasis in mutually adjusted Cox models, although these secondary analyses remain exploratory. Interpretation is limited by the small biopsy high-budding group (n = 10) and the limited number of events for several secondary outcomes. For later lymph-node metastasis, only resection-derived tumour budding remained statistically significant after mutual adjustment, whereas the association with biopsy-derived tumour budding was borderline. Resection-derived tumour budding, but not biopsy-derived tumour budding, remained associated with occult nodal metastasis after mutual adjustment, while no statistically significant specimen-type interactions were detected for the evaluated clinicopathological characteristics, with several estimates remaining imprecise.
Discussion: Preoperative biopsy-derived tumour budding may provide clinically relevant prognostic information in OSCC despite systematically underestimating high tumour budding. Although resection-based assessment showed a numerically higher C-index, biopsy assessment may provide complementary preoperative prognostic information but should not be considered a surrogate for resection-based assessment.
Related
- Prognostic Value of Tumor Budding and Worst Pattern of Invasion in Clinically Node-Negative Early-Stage Lip and Oral Cavity Squamous Cell Carcinoma: A Systematic Review
- Prognostic impact of the preoperative Naples prognostic score on overall and progression-free survival in surgically treated oral squamous cell carcinoma: A retrospective cohort study from a Taiwanese medical center.
- Preoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma
- Treatment patterns and prognostic factors of radiation-associated esophageal fistula in patients with esophageal squamous cell carcinoma: a retrospective cohort study
- Spatial Remodeling of the Immune Microenvironment During Laryngeal Carcinogenesis Reveals Prognostic Immune Patterns in Laryngeal Squamous Cell Carcinoma
BibTeX
@article{riese2026preoperative,
title = {{Preoperative biopsy underestimates tumour budding but retains prognostic value in oral squamous cell carcinoma}},
author = {Janik Riese and Claudio Cacchi and Julia Peppler and Guillaume Bonni and Julia Pannhausen and Anna Klein and Flurin Müller-Diesing and Danny Jonigk and Frank Hölzle and Maurice Klein},
journal = {Frontiers in oncology},
year = {2026},
month = sep,
doi = {10.3389/fonc.2026.1932265},
url = {https://europepmc.org/article/PMC/PMC13661392},
note = {CC BY},
}
RIS
TY - JOUR
TI - Preoperative biopsy underestimates tumour budding but retains prognostic value in oral squamous cell carcinoma
AU - Janik Riese
AU - Claudio Cacchi
AU - Julia Peppler
AU - Guillaume Bonni
AU - Julia Pannhausen
AU - Anna Klein
AU - Flurin Müller-Diesing
AU - Danny Jonigk
AU - Frank Hölzle
AU - Maurice Klein
PY - 2026
DA - 2026/09/30
JO - Frontiers in oncology
DO - 10.3389/fonc.2026.1932265
UR - https://europepmc.org/article/PMC/PMC13661392
AB - Introduction: Tumour budding is an established prognostic marker in oral squamous cell carcinoma (OSCC), but its reliability and prognostic performance in preoperative biopsy specimens remain uncertain. This study compared tumour budding assessment in matched biopsy and resection specimens and evaluated their respective prognostic value. Methods: We retrospectively analysed 256 patients with OSCC and matched preoperative biopsy and resection specimens. Tumour budding at the invasive front was assessed on hematoxylin and eosin-stained sections according to the International Tumour Budding Consensus Conference criteria and agreement between biopsy- and resection-based assessment was evaluated alongside associations with clinicopathological characteristics, disease-specific survival and occult nodal metastasis using logistic regression and Cox proportional hazards models. Results: Biopsy-derived tumour budding showed only weak correlation with resection findings and systematically underestimated high tumour budding, resulting in poor categorical agreement (κ = 0.11) and low sensitivity (9.8%) despite high specificity (98.9%). Nevertheless, both biopsy- and resection-based tumour budding were associated with disease-specific survival when mutually adjusted for each other. The C-index was numerically higher for resection-based than biopsy-based assessment (0.72 vs. 0.60), with only a modest increase when both measures were combined (C-index 0.74). Both biopsy- and resection-derived tumour budding were also associated with local recurrence and distant metastasis in mutually adjusted Cox models, although these secondary analyses remain exploratory. Interpretation is limited by the small biopsy high-budding group (n = 10) and the limited number of events for several secondary outcomes. For later lymph-node metastasis, only resection-derived tumour budding remained statistically significant after mutual adjustment, whereas the association with biopsy-derived tumour budding was borderline. Resection-derived tumour budding, but not biopsy-derived tumour budding, remained associated with occult nodal metastasis after mutual adjustment, while no statistically significant specimen-type interactions were detected for the evaluated clinicopathological characteristics, with several estimates remaining imprecise. Discussion: Preoperative biopsy-derived tumour budding may provide clinically relevant prognostic information in OSCC despite systematically underestimating high tumour budding. Although resection-based assessment showed a numerically higher C-index, biopsy assessment may provide complementary preoperative prognostic information but should not be considered a surrogate for resection-based assessment.
SN - 2234-943X
ER -